SWEDEN’S health regulator
has published a report on the
controversial PIP breast implants,
recommending that they be
removed from patients as a
precautionary measure.
According to the Swedish Medical
Products Agency, the PIP implants
“have a poorer mechanical
durability and, in a number of
cases, contain an irritant substance
in significantly higher levels than
other silicone breast implants”.
The most recent update on
the issue from the TGA said that
extensive testing “has not detected
the presence of any substances in
PIP silicone gel implants that are
toxic to human health”.The above article was sent to subscribers in Pharmacy Daily's issue from 06 Jun 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 06 Jun 13
MONTU Group, its subsidiary Alternaleaf Pty Ltd, and their common director Christopher Strauch are facing legal action by the Therapeutic Goods Administration (TGA) in the Federal Court of Australia for alleged unlawful advertising on the effectiveness of their medicinal cannabis products.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.